Severe Hemophilia A Active Not Recruiting Phase 3 Trials for Emicizumab (DB13923)

Also known as: Severe Haemophilia A / Hemophilia A, Severe

DBCOND0034640 (Severe Hemophilia A)Active Not Recruiting3 IdentifierTitlePurposeDrugs
NCT04431726A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without InhibitorsTreatment